Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (read-only, idempotent, open-world), the description adds substantial behavioral detail: multi-source resolution across EDGAR/GLEIF/OpenFIGI/RxNorm, graceful degradation when enrichment sources are unavailable, explicit `unresolved` output for missing identifiers, and non-assertion with `figi_candidates` on ambiguous name matches. It also warns that trailing security-class words will fail FIGI lookup. This far exceeds what annotations alone convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but appropriately front-loaded with trigger phrases and the primary instruction 'Use FIRST.' Every clause adds substantive detail, including edge cases and degradation behavior. It is somewhat dense and could be better organized into clearer sections, which keeps it from a perfect conciseness score.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with two required parameters and no output schema, the description is remarkably complete. It covers supported entity types, source provenance, ambiguity handling, unresolved identifiers, enrichment failures, and the internal multi-endpoint cascade. An agent has enough context to select and invoke the tool correctly and to interpret expected outcomes.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, yet the description still adds meaningful parameter semantics beyond the schema. It explains accepted input forms (ticker, CIK, ISIN, name; brand or generic drug), gives concrete examples, and includes the crucial caveat to pass only the entity name for bonds, since 'trailing security-class words match nothing.' The `type` enum is also elaborated with per-type resolution behavior.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a specific verb-plus-resource framing: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It also supplies concrete trigger phrases ('What's the ticker for…', 'find the CIK for…') and distinguishes itself from sibling tools by explaining that it maps names to IDs, not profiles or comparisons.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also clarifies scope through supported types and examples, and notes that one call replaces 2-3 manual lookups. However, it does not name alternatives or state when not to use it, so it lacks explicit exclusions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tools have overlapping or redundant purposes, most notably ask_pipeworx and ask_pipeworx_beta (currently identical), and the cluster of Polymarket tools (polymarket_edges, polymarket_arbitrage, bet_research) which all surface trading opportunities. While the lengthy descriptions help, an agent could easily select the wrong tool.

Naming Consistency4/5

All tool names use snake_case with a readable verb/noun structure, and there are no casing inconsistencies. However, the verb-first vs noun-first pattern is not uniformly applied (e.g., ask_pipeworx vs sarb_timeseries vs polymarket_edge_tracker), so it's mostly consistent with minor deviations.

Tool Count2/5

At 36 tools, the set is large and exceeds the 25-tool threshold; the broad scope justifies some volume but the presence of duplicate/overlapping tools (ask_pipeworx_beta, multiple Polymarket scanners) makes the count feel inflated.

Completeness4/5

The set covers a wide domain — SARB data, company research, prediction markets, AI visibility, memory, and subscriptions — with a good lifecycle for most features. Minor gaps exist (no subscription update, no bulk data export), but the core workflows are well covered.